Identification of a growth factor for primary murine stroma as macrophage colony-stimulating factor

Autor: EI Deryugina, BI Ratnikov, MA Bourdon, GL Gilmore, RK Shadduck, CE Muller- Sieburg

Publikováno v: Blood. 86(7)

Knowledge of the stromal microenvironment is crucial for understanding the hematopoietic system. We took advantage of an assay that permits analysis of primary stroma-initiating cells (SICs) on the clonal level, and further characterized SICs and the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::829aac45f46ccb7038dd0a097939804c
https://pubmed.ncbi.nlm.nih.gov/7670102

Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2

Autor: Ei, Deryugina, Ma, Bourdon, Ra, Reisfeld, Alex Strongin

Publikováno v: Europe PubMed Central

We assessed the functional significance of tumor cell-associated matrix metalloproteinase (MMP)-2 in extracellular matrix remodeling compared with that of the soluble enzyme by evaluating the contraction of three-dimensional collagen lattices by huma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9171e6a3e4a7bccf9ec0ed62870c0e62
http://europepmc.org/abstract/med/9721888

Investigation into the Mechanism(s) That Leads to Platelet Decreases in Cynomolgus Monkeys During Administration of ISIS 104838, a 2'-MOE-Modified Antisense Oligonucleotide.

Autor: Narayanan P; Nonclinical Development, Ionis Pharmaceuticals Inc, Carlsbad, California, 92010., Shen L; Nonclinical Development, Ionis Pharmaceuticals Inc, Carlsbad, California, 92010., Curtis BR; Blood Research Institute Blood Center Wisconsin, Milwaukee, Wisconsin 53236., Bourdon MA; BioLaurus Inc. San Diego, California 92166., Nolan JP; Cellarcus Technologies, La Jolla, California 92037., Gupta S; Shin Nippon Biomedical Laboratories (SNBL), Everett, Washington., Hoffmaster C; Nonclinical Development, Ionis Pharmaceuticals Inc, Carlsbad, California, 92010., Zhou F; Department of Medicine, University of California San Diego, La Jolla, CA, 92093., Christian B; Acuimmune, Chatsworth, California 91311., Schaubhut JL; Shin Nippon Biomedical Laboratories (SNBL), Everett, Washington., Greenlee S; Nonclinical Development, Ionis Pharmaceuticals Inc, Carlsbad, California, 92010., Burel SA; Nonclinical Development, Ionis Pharmaceuticals Inc, Carlsbad, California, 92010., Witztum JL; Department of Medicine, University of California San Diego, La Jolla, CA, 92093., Engelhardt JA; Nonclinical Development, Ionis Pharmaceuticals Inc, Carlsbad, California, 92010., Henry SP; Nonclinical Development, Ionis Pharmaceuticals Inc, Carlsbad, California, 92010.

Publikováno v: Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2018 Aug 01; Vol. 164 (2), pp. 613-626.

Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2.

Autor: Deryugina EI; La Jolla Institute for Experimental Medicine, La Jolla, California 92037, USA., Bourdon MA, Reisfeld RA, Strongin A

Publikováno v: Cancer research [Cancer Res] 1998 Aug 15; Vol. 58 (16), pp. 3743-50.

Novel splice variants of human tenascin-C mRNA identified in normal and bullous keratopathy corneas.

Autor: Saghizadeh M; Ophthalmology Research Laboratories, Burns and Allen Research Institute, Cedars-Sinai Medical Center, UCLA Medical School Affiliate, Los Angeles, California 90048, USA., Khin HL, Bourdon MA, Kenney MC, Ljubimov AV

Publikováno v: Cornea [Cornea] 1998 May; Vol. 17 (3), pp. 326-32.